Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient
Nelwan, E.J.
Acta Medica Indonesiana 46(4): 273-274
2014
ISSN/ISBN: 0125-9326 PMID: 25633542 Document Number: 678190
Document emailed within 1 workday
Related Documents
Domingos, H.; Cunha, R.V.ân.d.; Paniago, A.M.M.; Martins, D.M.; Elkhoury, E.B.ão.; Souza, A.S.d. 2009: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(2): 130-136Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715s
Ruanjahn, G.; Roberts, D.; Monterosso, L. 2010: An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand Aids Care 22(12): 1555-1561
Luo, J.; Jing, D.; Kozak, I.; Huiming, Z.; Siying, C.; Yezhen, Y.; Xin, Q.; Luosheng, T.; Adelman, R.A.; Forster, S.H. 2013: Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China Ophthalmic Epidemiology 20(3): 170-175
Fonseca, M.Goretti.P.; Lucena, F.de.Fátima.A.; Sousa, A.de.; Bastos, F.I. 2007: AIDS mortality, "race or color", and social inequality in a context of universal access to highly active antiretroviral therapy (HAART) in Brazil, 1999-2004 Cadernos de Saude Publica 23 Suppl. 3: S445-S455
Olisah, V.O.; Baiyewu, O.; Sheikh, T.L. 2010: Adherence to highly active antiretroviral therapy in depressed patients with HIV/AIDS attending a Nigerian university teaching hospital clinic African Journal of Psychiatry 13(4): 275-279
Apanga, S.; Punguyire, D.; Adjei, G. 2012: Estimating the cost to rural ambulating HIV/AIDS patients on highly active antiretroviral therapy (HAART) in rural Ghana: a pilot study Pan African Medical Journal 12: 21
Edlin, B.R. 1999: Change of HAART. Highly active antiretroviral therapy Lancet 353(9167): 1888
Afolabi, B.A.; Afolabi, M.O.; Afolabi, A.A.; Odewale, M.A.; Olowookere, S.A. 2013: Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria African Health Sciences 13(4): 920-926
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Lapphra, K.; Vanprapar, N.; Phongsamart, W.; Chearskul, P.; Chokephaibulkit, K. 2005: Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 88(7): 956-966
Jáuregui Camargo, L.; Ruiz-Palacios, G.; Guerrero Almeida, L.; Niño Oberto, S.; Peasey, A.; Sierra Madero, J. 2003: Evaluation of highly active antiretroviral therapy (HAART) in a cohort of patients with HIV infection in Mexico Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(1): 10-17
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Bedingfield, N.; Kipp, W.; Kaler, A.; Rubaale, T. 2014: Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda Aids Care 26(1): 75-78
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Harvey, K.M.; Carrington, D.; Duncan, J.; Figueroa, J.P.; Hirschorn, L.; Manning, D.; Jackson, S. 2008: Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica West Indian Medical Journal 57(3): 293-297